Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups.

Chia, Y.C. and Yeoh, E.S. and Ng, C.J. and Khoo, E.M. and Chua, C.T. (2009) Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups. Singapore Medical Journal, 50 (5). pp. 500-5. ISSN 0037-5675

[img]
Preview
PDF
Efficacy_and_tolerability_of_lercanidipine_in_mild_to_moderate_hyperetnsion_Chia_YC_SMJ_2009.pdf

Download (464kB)
Official URL: http://www.ncbi.nlm.nih.gov/pubmed/19495520

Abstract

Introduction: Calcium channel blockers are well established modalities for the treatment of hypertension. However, in spite of the availability of many efficacious agents, hypertension control continues to be poor. One reason is poor tolerability due to adverse events. Racial differences also exist. Lercanidipine, a third-generation calcium channel blocker, is associated with better tolerability. However, it has not been studied in the Asian population. This study examines its efficacy and tolerability in Asian subjects of different ethnicities. Methods: This was an eight-week open label study of adults with mild to moderate hypertension. Blood pressure (BP), pulse rate, self-administered symptom check and laboratory evaluations were done at baseline. Patients were prescribed 10 mg lercanidipine, with up-titration to 20 mg if BP was not controlled at Week 4. Baseline evaluations were repeated at Week 8. Adverse events were also enumerated. Results: 27 patients (mean age 53.4 +/- 12.1 years) completed the study. The baseline systolic BP (SBP), diastolic BP (DBP) and heart rate was 159 +/- 12.2, 96.6 +/- 7.7 mmHg and 71 +/- 13/min, respectively. Three racial groups were represented. SBP and DBP decreased significantly after four weeks of therapy. A further reduction to 139 +/- 14.3 and 88 +/- 9.8 (p-value is less than 0.0001) was seen in Week 8. The absolute SBP and DBP reduction was 20.5 mmHg (95 percent confidence interval [CI] 16.5-24.5, p-value is less than 0.0001) and 9.3 mmHg (95 percent CI 6.2-12.5, p-value is less than 0.0001), respectively. All adverse symptoms, except for palpitations, were reduced at the end of the study. Conclusion: Lercanidipine is efficacious and well tolerated in Asians of different ethnicities. Its BP lowering effects and tolerability in Asians appear to be similar to other studies on Caucasians and other calcium channel blockers.

Item Type: Article
Additional Information: Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia
Uncontrolled Keywords: Antihypertensive Agents/adverse effects; Asia/ethnology
Subjects: R Medicine
Divisions: Faculty of Medicine
Depositing User: Mr. Faizal Hamzah
Date Deposited: 29 Apr 2011 02:24
Last Modified: 14 Jan 2019 01:20
URI: http://eprints.um.edu.my/id/eprint/1115

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year